External validation of population pharmacokinetic models of vancomycin in postoperative neurosurgical patients

Reuter SE, Stocker SL, Alffenaar JC, Baldelli S, Cattaneo D, Jones G et al (2022) Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit 44(1):121–132

Article  CAS  PubMed  Google Scholar 

Schneider F, Gessner A, El-Najjar N (2022) Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update. Antibiotics (Basel) 11(2):173

Article  CAS  PubMed  Google Scholar 

Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM et al (2017) 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 64(6):e34–e65

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasbun R (2021) Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies. Expert Rev Anti Infect Ther 19(8):993–999

Article  CAS  PubMed  Google Scholar 

Lin WW, Wu W, Jiao Z, Lin RF, Jiang CZ, Huang PF et al (2016) Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens. Eur J Clin Pharmacol 72(1):29–37

Article  CAS  PubMed  Google Scholar 

Aljefri DM, Avedissian SN, Rhodes NJ, Postelnick MJ, Nguyen K, Scheetz MH (2019) Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis. Clin Infect Dis 69(11):1881–1887

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy M, Girdwood ST, Scheetz MH (2020) Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin. J Hosp Med 15(12):740–742

Article  PubMed  PubMed Central  Google Scholar 

Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C et al (2020) Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 71(6):1361–1364

Article  CAS  PubMed  Google Scholar 

Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D et al (2020) Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper(). Intensive Care Med 46(6):1127–1153

Article  PubMed  PubMed Central  Google Scholar 

Lin Z, Chen DY, Zhu YW, Jiang ZL, Cui K, Zhang S et al (2021) Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units. Sci Rep 11(1):2670

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang W, He B, Deng C (2017) Population pharmacokinetics of vancomycin from severe in patients with lower respiratory tract infection. Chinese J Tubercul Respir Dis 40(03):205–209

CAS  PubMed  Google Scholar 

del Mar F, de Gatta Garcia M, Revilla N, Calvo MV, Domínguez-Gil A, Sánchez Navarro A (2007) Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 33(2):279–85

Bang JY, Kang HI, Lee HJ, Chong YP, Hong SK, Lee EK et al (2022) Development of a new pharmacokinetic model for target-concentration controlled infusion of vancomycin in critically ill patients. Clin Exp Pharmacol Physiol 49(2):202–211

Article  CAS  PubMed  Google Scholar 

Revilla N, Martín-Suárez A, Pérez MP, González FM, Fernández de Gatta Mdel M (2010) Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Br J Clin Pharmacol 70(2):201–212

Alqahtani SA, Alsultan AS, Alqattan HM, Eldemerdash A, Albacker TB (2018) Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens. Antimicrob Agents Chemother 62(7):e00088-e118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Economou CJP, Kielstein JT, Czock D, Xie J, Field J, Richards B et al (2018) Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy. Int J Antimicrob Agents 52(2):151–157

Article  CAS  PubMed  Google Scholar 

Garreau R, Falquet B, Mioux L, Bourguignon L, Ferry T, Tod M et al (2021) Population pharmacokinetics and dosing simulation of vancomycin administered by continuous injection in critically ill patient. Antibiotics (Basel) 10(10):1228

Article  CAS  PubMed  Google Scholar 

Kanji S, Roberts JA, Xie J, Zelenitsky S, Hiremath S, Zhang G et al (2020) Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis. Clin Pharmacokinet 59(3):327–334

Article  CAS  PubMed  Google Scholar 

Mangin O, Urien S, Mainardi JL, Fagon JY, Faisy C (2014) Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis. Clin Pharmacokinet 53(9):849–861

Article  CAS  PubMed  Google Scholar 

Medellín-Garibay SE, Romano-Moreno S, Tejedor-Prado P, Rubio-Álvaro N, Rueda-Naharro A, Blasco-Navalpotro MA et al (2017) Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically ill Patients. Antimicrob Agents Chemother 61(12):e01249-e1317

Article  PubMed  PubMed Central  Google Scholar 

Wang C, Zhang C, Li X, Zhao S, He N, Zhai S et al (2021) Dose optimization of vancomycin for critically ill patients undergoing CVVH: A prospective population PK/PD analysis. Antibiotics (Basel) 10(11):1392

Article  CAS  PubMed  Google Scholar 

Jalusic KO, Hempel G, Arnemann PH, Spiekermann C, Kampmeier TG, Ertmer C et al (2021) Population pharmacokinetics of vancomycin in patients with external ventricular drain-associated ventriculitis. Br J Clin Pharmacol 87(6):2502–2510

Article  CAS  PubMed  Google Scholar 

Li X, Sun S, Ling X, Chen K, Wang Q, Zhao Z (2017) Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration. Eur J Clin Pharmacol 73(12):1599–1607

Article  CAS  PubMed  Google Scholar 

Li X, Wu Y, Sun S, Mei S, Wang J, Wang Q et al (2015) Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients. J Pharm Sci 104(11):3960–3967

Article  CAS  PubMed  Google Scholar 

Jing L, Liu TT, Guo Q, Chen M, Lu JJ, Lv CL (2020) Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers. J Clin Pharm Ther 45(1):88–96

Article  CAS  PubMed  Google Scholar 

Wei S, Zhang D, Zhao Z, Mei S (2022) Population pharmacokinetic model of vancomycin in postoperative neurosurgical patients. Front Pharmacol 13:1005791

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vandecasteele SJ, De Vriese AS, Tacconelli E (2013) The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. J Antimicrob Chemother 68(4):743–748

Article  CAS  PubMed  Google Scholar 

Zhang J, Lin W, Wu W, Guo X, Huang P, Lin X et al (2020) Population pharmacokinetics of vancomycin in Chinese elderly patients and its application for dose individualisation. J Chin Pharm Sci 29(4):260–271

Article  CAS  Google Scholar 

Kim AJ, Lee JY, Choi SA, Shin WG (2016) Comparison of the pharmacokinetics of vancomycin in neurosurgical and non-neurosurgical patients. Int J Antimicrob Agents 48(4):381–387

Article  CAS  PubMed  Google Scholar 

Chen Y, Liu L, Zhu M (2020) Effect of augmented renal clearance on the therapeutic drug monitoring of vancomycin in patients after neurosurgery. J Int Med Res 48(10):300060520949076

Article  CAS  PubMed  Google Scholar 

Kirubakaran R, Stocker SL, Hennig S, Day RO, Carland JE (2020) Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review. Clin Pharmacokinet 59(11):1357–1392

Article  CAS  PubMed  Google Scholar 

Zhou Y, Long E, Shi T, Wang Z, Zhao J, Liu H et al (2022) External validation of vancomycin population pharmacokinetic models in ten cohorts of infected Chinese patients. J Glob Antimicrob Resist 30:163–172

Article  CAS  PubMed  Google Scholar 

Cheng Y, Wang CY, Li ZR, Pan Y, Liu MB, Jiao Z (2021) Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations Clin Pharmacokinet 60(1):53–68

CAS  PubMed  Google Scholar 

Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41

Article  CAS  PubMed  Google Scholar 

Kong X, Ma Y, Chen J, Luo Q, Yu X, Li Y et al (2013) Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant 28(3):641–651

Article  CAS  PubMed  Google Scholar 

Hara M, Masui K, Eleveld DJ, Struys M, Uchida O (2017) Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia. Br J Anaesth 118(3):415–423

Article  CAS  PubMed 

留言 (0)

沒有登入
gif